|
CN111297822A
|
|
Rivaroxaban pellet capsule and preparation method thereof
|
|
CN110917170A
|
|
Candesartan cilexetil-containing capsule preparation and preparation method thereof
|
|
CN110840856A
|
|
Composition containing linagliptin and application thereof
|
|
CN109970763A
|
|
A kind of preparation method of DGAT1 inhibitor
|
|
CN108033929A
|
|
A kind of synthetic method of gout suppressant Febustat intermediate impurities and its application for synthesizing impurity
|
|
CN107753457A
|
|
A kind of nifedipine micropore permeation pump clad sheet with expansion label and preparation method thereof
|
|
CN107773555A
|
|
A kind of nifedipine micropore permeation pump particulate and preparation method thereof
|
|
CN106749195A
|
|
A kind of olmesartan medoxomil intermediate impurities synthesis, the method for identification
|
|
CN106831727A
|
|
A kind of method for synthesizing olmesartan medoxomil intermediate impurities
|
|
CN106699627A
|
|
Method for preparing 1-(2-chloracetyl)-2-(S)-cyano pyrrolidine through multiphase compound non-continuous production process
|
|
CN106727325A
|
|
A kind of Liposomal formulation of imatinib mesylate and preparation method thereof
|
|
CN106890326A
|
|
A kind of enteric-coated micro-pill and its preparation containing phosphoesterases complex
|
|
CN106890148A
|
|
A kind of dabigatran etcxilate tablet and its preparation
|
|
CN106892879A
|
|
A kind of synthetic method of gout suppressant Febustat
|
|
CN105153118A
|
|
Central control method of midbody in dabigatran etexilate mesylate preparation process
|
|
CN105112384A
|
|
Extracting and drying method of phosphodiesterase complex
|
|
CN104892595A
|
|
Production method of palonosetron hydrochloride
|
|
CN104693186A
|
|
Method for synthesizing zepam type drugs by converting C-F bond in indole derivatives into C-N bond
|
|
CN104672123A
|
|
Oxiracetam refining and purifying method
|
|
CN104650037A
|
|
Synthesis method of dabigatran etexilate
|
